PODD
Insulet Corporation

1,896
Mkt Cap
$20.24B
Volume
588,226.00
52W High
$354.88
52W Low
$230.05
PE Ratio
82.47
PODD Fundamentals
Price
$284.25
Prev Close
$287.70
Open
$285.51
50D MA
$303.86
Beta
0.85
Avg. Volume
671,680.82
EPS (Annual)
$5.78
P/B
14.45
Rev/Employee
$531,179.49
Loading...
Loading...
News
all
press releases
Is Insulet (PODD) the Future of Diabetes Management?
Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market...
Nasdaq News: Markets·2h ago
News Placeholder
More News
News Placeholder
Insulet Corporation $PODD Shares Purchased by Stephens Investment Management Group LLC
Stephens Investment Management Group LLC lifted its position in Insulet Corporation (NASDAQ:PODD - Free Report) by 5.2% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·4d ago
News Placeholder
Nisa Investment Advisors LLC Sells 4,201 Shares of Insulet Corporation $PODD
Nisa Investment Advisors LLC lowered its holdings in Insulet Corporation (NASDAQ:PODD - Free Report) by 48.9% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·6d ago
News Placeholder
Insulet (NASDAQ:PODD) Downgraded to Equal Weight Rating by Barclays
Barclays lowered Insulet from an "overweight" rating to an "equal weight" rating and set a $274.00 price objective for the company. in a research note on Monday...
MarketBeat·9d ago
News Placeholder
Here's Why Insulet (PODD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·11d ago
News Placeholder
Insulet (NASDAQ:PODD) Rating Lowered to "Hold" at Zacks Research
Zacks Research lowered shares of Insulet from a "strong-buy" rating to a "hold" rating in a report on Monday...
MarketBeat·14d ago
News Placeholder
Asset Management One Co. Ltd. Has $11.86 Million Stock Holdings in Insulet Corporation $PODD
Asset Management One Co. Ltd. raised its position in Insulet Corporation (NASDAQ:PODD - Free Report) by 29.0% during the 3rd quarter, according to its most recent filing with the SEC. The...
MarketBeat·14d ago
News Placeholder
Insulet Redefines Diabetes at CES with "Liveable Technology" A New Frontier in Human-Centered Connected Health
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced its debut at Consumer...
Business Wire·15d ago
News Placeholder
Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare benefits from e-commerce momentum, acquisitions and solid solvency, even as inflation and tariff costs pose near-term risks.
Zacks·19d ago
News Placeholder
Is it the Right Time to Add Insulet Stock to Your Portfolio?
PODD gains momentum as Omnipod 5 adoption accelerates, margins scale, and earnings estimates rise despite macro and concentration risks.
Zacks·19d ago
<
1
2
...
>

Latest PODD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.